Pulse Biosciences Inc

NASDAQ:PLSE 4:00:00 PM EDT

16.64

+0.90 (+5.72%)

5:17:48 PM EDT: $17.00 +0.36 (+2.16%)

Market Cap (Intraday)	1.03B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.5 Million
Adjusted EPS	-$0.31

See more estimates

10-Day MA	$15.46
50-Day MA	$15.51
200-Day MA	$17.16

See more pivots

Pulse Biosciences Inc Stock, NASDAQ:PLSE

3957 Point Eden Way, 3957 Point Eden Way, Hayward, California 94545

United States of America

Phone: +1.510.906.4600

Number of Employees: 56

http://www.pulsebiosciences.com

Description

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.